# Azole Resistance in Candida parapsilosis From Patients With Burns in Mexico: A Genomic and Phylogenetic Analysis

**Authors:** María de Lourdes García‐Hernández, Luis Ángel Nuñez‐García, Jossue Ortíz‐Álvarez, Marco Antonio Delaye‐Martínez, Marlen Flores‐Huacuja, María del Rocío Vazquez‐Olivares, Luis Fernando Espinosa‐Camacho, Gabriela Delgado‐Sapien, María del Rosario Morales‐Espinosa, Noé Becerra‐Lobato, Rafael Franco‐Cendejas, Elvira Garza‐González, Luis Ostrosky‐Zeichner, Tatiana Chávez‐Heres, Melissa Hernández‐Durán, Luis Esaú López‐Jácome, Claudia Adriana Colín‐Castro

PMC · DOI: 10.1111/myc.70161 · Mycoses · 2026-03-07

## TL;DR

This study analyzes Candida parapsilosis strains from burn patients in Mexico to understand azole resistance patterns and genetic variants.

## Contribution

The study identifies specific genetic mutations linked to azole resistance in C. parapsilosis from clinical isolates in Mexico.

## Key findings

- Most isolates were Candida parapsilosis sensu stricto, with 33% showing fluconazole resistance.
- The ERG11 Y132F variant was common in resistant isolates.
- Two haplotypes were identified through SNP and phylogenetic analysis.

## Abstract

Candida species are common causes of nosocomial infections. 
Candida parapsilosis
 has emerged as an important pathogen. Mortality rates associated with invasive 
C. parapsilosis
 infections range from 14.5% to 47%, with azole resistance estimated between 4% and 15%. Resistance mechanisms include mutations in ERG11 that diminish azole binding, upregulation of ergosterol biosynthesis genes due to mutations in regulatory factors like UPC2 and NDT80, and increased efflux pump activity.

Thirty clinical strains of the 
C. parapsilosis
 complex were isolated from bloodstream cultures, biopsies and catheter tips from hospitalised patients from a major rehabilitation centre in Mexico between June 2011 and August 2016. Minimum inhibitory concentrations for fluconazole, voriconazole, itraconazole, caspofungin, micafungin, anidulafungin and amphotericin B were determined using the broth microdilution method. Whole genome sequencing was conducted using Illumina technology, with subsequent assembly and annotation. Analyses included antifungal resistance variant screening, SNP distance, average nucleotide identity and phylogenetic comparisons with publicly available genomes.

Most strains (96.7%, 29/30) were identified as 
C. parapsilosis
 sensu stricto, predominantly isolated from blood. Thirty‐three percent of isolates showed phenotypic resistance to fluconazole. The SNP‐distance and maximum‐likelihood phylogenetic analyses revealed two distinct haplotypes and the genotype 1: ERG11
WT/Y132F, CDR1
I1287V/I1287V and UPC2
WT/N455D was the most represented (8/10 isolates).

C. parapsilosis
 sensu stricto was the predominant species isolated, with a notable proportion exhibiting resistance to FLU and VOR. The Y132F variant in the ERG11 gene was present in most sequenced isolates.

## Linked entities

- **Genes:** ERG11 (sterol 14-demethylase) [NCBI Gene 856398], CDR1 (cerebellar degeneration related 1) [NCBI Gene 1038], UPC2 (Upc2p) [NCBI Gene 851799], MYRF (myelin regulatory factor) [NCBI Gene 745]
- **Chemicals:** fluconazole (PubChem CID 3365), voriconazole (PubChem CID 71616), itraconazole (PubChem CID 55283), caspofungin (PubChem CID 16119814), micafungin (PubChem CID 477468), anidulafungin (PubChem CID 166548), amphotericin B (PubChem CID 1972)
- **Diseases:** burns (MONDO:0043519)

## Full-text entities

- **Diseases:** AMB (MESH:D006509), C. parapsilosis  infections (MESH:D007239), TSBA (MESH:D010534), C. metapsilosis (OMIM:211750), death (MESH:D003643), nosocomial infections (MESH:D003428), Invasive candidiasis (MESH:D058365), bloodstream infection (MESH:D018805), Burns (MESH:D002056), fungal (MESH:D009181), Candida parapsilosis (MESH:D002177), bacterial infections (MESH:D001424), Brain Heart Infusion (MESH:D000075662)
- **Chemicals:** Azole (MESH:D001393), MCF (MESH:D000077551), AMB (MESH:D000666), ergosterol (MESH:D004875), AND (MESH:D000077612), glycerol (MESH:D005990), Nucleic Lysis (-), CAS (MESH:D000077336), ethanol (MESH:D000431), VOR (MESH:D065819), echinocandins (MESH:D054714), FLU (MESH:D015725), ITC (MESH:D017964)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Candida [taxon 1535326], Pseudomonas aeruginosa (species) [taxon 287], Lodderomyces parapsilosis (species) [taxon 5480], Pichia kudriavzevii (species) [taxon 4909], Candida albicans (species) [taxon 5476], Lodderomyces orthopsilosis (species) [taxon 273371], Acinetobacter baumannii (species) [taxon 470], Lodderomyces parapsilosis CDC317 (strain) [taxon 578454]
- **Mutations:** K143R, N455D, Y132F, M57S, Y132F, I1287V, N1132D, N455D, I1287V
- **Cell lines:** H029 — Homo sapiens (Human), Laryngeal squamous cell carcinoma, Cancer cell line (CVCL_5993)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12966976/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966976/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12966976/full.md

---
Source: https://tomesphere.com/paper/PMC12966976